Literature DB >> 6602124

Ventricular cerebrospinal fluid concentrations of trimethoprim-sulphamethoxazole.

E E Wang, C G Prober.   

Abstract

Ventricular cerebrospinal fluid (CSF) trimethoprim-sulphamethoxazole (TMP-SMZ) concentrations were measured in 15 patients. At varying times, not exceeding eight hours prior to surgery, each patient received a dose of 5 mg/kg TMP with 25 mg/kg SMZ as a 1 h intravenous infusion. The mean ventricular CSF TMP concentration was 1.1 mg/l with a range of 0.5-3.2 mg/l. The SMZ concentration was 17.9 mg/l with a range of 5-40 mg/l. There was no apparent relationship between achievable CSF concentrations and the time elapsed after drug administration. The CSF concentrations were achieved despite the lack of meningeal inflammation. In 11 of 14 patients, the levels exceeded the minimum inhibitory concentrations for Staphylococcus aureus and Staph. epidermidis.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6602124     DOI: 10.1093/jac/11.4.385

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  9 in total

Review 1.  Whipple's disease revisited.

Authors:  S A Misbah; N P Mapstone
Journal:  J Clin Pathol       Date:  2000-10       Impact factor: 3.411

2.  Recovery from bilateral wrist-drop in Whipple's disease.

Authors:  T J Cooper; G Bird; B White; I T Ferguson
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-01       Impact factor: 10.154

Review 3.  Penetration of drugs through the blood-cerebrospinal fluid/blood-brain barrier for treatment of central nervous system infections.

Authors:  Roland Nau; Fritz Sörgel; Helmut Eiffert
Journal:  Clin Microbiol Rev       Date:  2010-10       Impact factor: 26.132

4.  A Drug-Tunable Gene Therapy for Broad-Spectrum Protection against Retinal Degeneration.

Authors:  Clayton P Santiago; Casey J Keuthan; Sanford L Boye; Shannon E Boye; Aisha A Imam; John D Ash
Journal:  Mol Ther       Date:  2018-07-19       Impact factor: 11.454

5.  Chryseobacterium indologenes central nervous system infection in infancy: an emergent pathogen?

Authors:  P Olbrich; M Rivero-Garvía; M D Falcón-Neyra; J A Lepe; J M Cisneros; J Marquez-Rivas; O Neth
Journal:  Infection       Date:  2013-05-25       Impact factor: 3.553

6.  Pharmacokinetics of trimethoprim and sulfamethoxazole in serum and cerebrospinal fluid of adult patients with normal meninges.

Authors:  M N Dudley; R E Levitz; R Quintiliani; J M Hickingbotham; C H Nightingale
Journal:  Antimicrob Agents Chemother       Date:  1984-12       Impact factor: 5.191

7.  An evaluation of antimicrobial treatment for Whipple's Disease. Tetracycline versus trimethoprim-sulfamethoxazole.

Authors:  G E Feurle; T Marth
Journal:  Dig Dis Sci       Date:  1994-08       Impact factor: 3.199

8.  Clinical Presentation, Management, and Outcomes of Patients With Brain Abscess due to Nocardia Species.

Authors:  Cristina Corsini Campioli; Natalia E Castillo Almeida; John C O'Horo; Douglas Challener; John Raymond Go; Daniel C DeSimone; M Rizwan Sohail
Journal:  Open Forum Infect Dis       Date:  2021-04-07       Impact factor: 3.835

Review 9.  [Antibiotic diffusion to central nervous system].

Authors:  J M Cabrera-Maqueda; L Fuentes Rumí; G Valero López; A E Baidez Guerrero; E García Molina; J Díaz Pérez; E García-Vázquez
Journal:  Rev Esp Quimioter       Date:  2018-01-31       Impact factor: 1.553

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.